Title: Assessment of fenofibrate micronised lipanthyl 200mg therapy in hyperlipidemia
Abstract: Objective To assess the effect and safety of fenofibrate micronised lipanthyl 200mg in hyperlipidemia.Methods In an open and randomized prospective study,98 patients with hyperlipidemia were divided into two groups,in which one was treated with fenofibrate,another with douxikang for 12 weeks.Clinical data,laboratory results and side effects of both therapies were analyzed.Results The rate of decrease of serum cholesterol,triglyceride,low density lipoprotein were 18.9%(P0.01),44%(P0.001),13%(P0.05) in order in fenofibrate group,meanwhile,in duoxikang group,were 11%,19%,13.7%(P0.05).The effective rate of 79.1% in fenofibrate group and 48.8% in duoxikang group were found,which suggested significantly fenofibrate therapy was more effective than douxikang therapy in hyperlipidemia(P0.01).Conclusion Fenofibrate is an effective and safe therapy in hyperlipidemia,and more effective than duoxikang.
Publication Year: 2001
Publication Date: 2001-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot